Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling

Elsevier Science Inc
Publication Type:
Journal Article
Bone, 2008, 43 (4), pp. 653 - 662
Issue Date:
Full metadata record
Files in This Item:
Filename Description SizeFormat
2008000176OK.pdf2.22 MBAdobe PDF
Introduction: It has been widely assumed that osteoclasts play a pivotal role during the entire process of fracture healing. Bisphosphonates (Bps) are anti-catabolic agents commonly used to treat metabolic bone diseases including osteoporosis, minimizing
Please use this identifier to cite or link to this item: